Emergent BioSolutions
EBS
#8541
Rank
C$0.37 B
Marketcap
C$7.38
Share price
-6.36%
Change (1 day)
-46.83%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -C$0.28 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are C$0.62 Billion. In 2025 the company made an earning of C$0.20 Billion, an increase over its 2024 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.28 Billion-235.17%
2025 C$0.20 B-297.64%
2024 -C$0.11 Billion-88.82%
2023 -C$0.93 Billion242.73%
2022 -C$0.27 Billion-153.8%
2021 C$0.50 B-20.43%
2020 C$0.62 B278.02%
2019 C$0.16 B27.11%
2018 C$0.13 B-27.12%
2017 C$0.17 B17.21%
2016 C$0.15 B0.45%
2015 C$0.15 B73.51%
2014 C$87.89 M41.36%
2013 C$62.18 M35.2%
2012 C$45.99 M0.4%
2011 C$45.8 M-56.46%
2010 C$0.10 B76.73%
2009 C$59.53 M32.94%
2008 C$44.78 M-5.62%
2007 C$47.44 M
2005 C$68.69 M269.89%
2004 C$18.57 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.99 B-3,680.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.63 B-3,554.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$10.25 B-3,776.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-C$16.79 Million-93.99%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-C$15.97 Million-94.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.47 Billion 67.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.75 B-728.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel